aktiia, a Neuchatel, Switzerland-based blood pressure monitoring company, raised a CHF4m seed funding round.
The round was led by Redalpine and TransLink Capital.
The company intends to use the funds to further develop and validate its algorithms and product offerings as well as establish strategic third-party partnerships.
Led by Mattia Bertschi, co-founder and CEO, aktiia provides patented technology that combines common optical sensors, widely-known for tracking heart-rate in today’s wearables, and clinically validated software algorithms to measure an individual’s blood pressure continuously at the wrist.
The algorithms will be embedded in non-medical third-party wearables for preventive purposes to track blood pressure trends, as well as in its medical grade wearable to monitor precise blood pressure values that can be used for the diagnosis and management of hypertension.